# Janux Therapeutics, Inc.: Form DEF 14A, filed Apr 25, 2025

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: DEF 14A
- Filed: 2025-04-25
- Accepted by EDGAR: Apr 25, 2025, 16:39 ET
- Period: 2025-04-25
- Accession: 0000950170-25-058806
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000095017025058806/janx-20250424.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000095017025058806/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000095017025058806/janx-20250424.htm

Filed Apr 25, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-058806. Last ingested by Listed: Nov 5, 2026, 18:20 ET. No prices; not investment advice.